Spanish Luxury Stock News

BME:COXG
BME:COXGRenewable Energy

Cox Infrastructure Group (BME:COXG) Stock Revenue Climbs As Losses Deepen

Cox Infrastructure Group shares came into this earnings print on the back foot, with the stock down around 6% over the past month, yet the headline story is not the share price. The real shock is on the income line. Over the last twelve months the company swung from profit to a loss of €56.8 million, even as revenue reached €1.53b. That profit squeeze is what the market is trying to price in today, and it sets the emotional tone for how investors will read the rest of this report. Concerned...
BME:ALM
BME:ALMPharmaceuticals

Is Almirall (BME:ALM) Undervalued After Half Year Results And Guidance Reiteration?

Almirall (BME:ALM) is in focus after reporting half year 2026 results on 24 July, alongside a reiteration of full year guidance for net sales growth of 9% to 12%. See our latest analysis for Almirall. The reiteration of guidance comes after a mixed year for Almirall’s share price, with a 7-day share price return of 4.75% and a year-to-date share price return down 11.16%. The 3-year total shareholder return of 39.16% shows stronger longer term momentum. If today’s update has you thinking about...
BME:ECR
BME:ECRChemicals

Ercros (BME:ECR) Stock Returns To Profit But Durability Remains Unclear

Ercros stock closed at €3.485, with recent returns barely moving the needle over the past week and month. The share price looks calm on the surface. The earnings print is anything but. Q2 revenue landed at €214.397 million and flipped the company back into profit with net income of €9.705 million, after a run of quarterly losses. For a chemicals producer that has been unprofitable over the last twelve months and is expected to stay that way in forecasts, this single profitable quarter stands...
BME:VID
BME:VIDPackaging

Vidrala (BME:VID) Reaffirmed Targets, Is The Stock Still Cheap?

Why Vidrala’s latest earnings matter for shareholders Vidrala (BME:VID) has moved back into focus after its half year 2026 earnings on 23 July, with rising profit, firmer margins and a clear reaffirmation of full year financial targets. For the six months to 30 June 2026, Vidrala reported sales of €755.04 million compared with €751.14 million a year earlier. Net income was €117.4 million against €107.84 million, with basic earnings per share at €3.36 versus €3.0667. See our latest analysis...
BME:ART
BME:ARTElectrical

European Stock Picks Possibly Trading Below Intrinsic Value Estimates In July 2026

The European stock market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 0.46% amid robust corporate earnings and geopolitical tensions impacting oil prices. As investors navigate these complex conditions, identifying stocks that may be trading below their intrinsic value can present opportunities for those seeking potential growth in a volatile environment.
BME:ENG
BME:ENGGas Utilities

Enagás (BME:ENG) H1 Earnings Put Its Undervalued Narrative Back In Focus

How Enagás earnings set the context for the stock Enagás (BME:ENG) has just reported half year 2026 results, with sales of €444.63 million and net income of €126.91 million, both lower than the same period a year earlier. Basic and diluted earnings per share from continuing operations were €0.49, compared with €0.68 a year ago. This gives investors fresh information to reassess how the stock’s current price reflects these figures. See our latest analysis for Enagás. Since the H1 2026 earnings...
BME:SAB
BME:SABBanks

Banco de Sabadell (BME:SAB) Stock Faces Margin Pressure As Q2 Net Interest Margin Slips To 1.79%

Banco de Sabadell (BME:SAB) has reported Q2 2026 results with total revenue of €1,396 million and net income of €624 million, setting the tone for how the rest of the year may shape up for shareholders. The company has seen quarterly revenue move from €1,362 million in Q4 2025 to €1,046 million in Q1 2026 and then to €1,396 million in Q2 2026, while basic EPS tracked at €0.0776 in Q4 2025 and €0.0705 in Q1 2026. This gives investors a clearer view of how the top and bottom lines are pacing...
BME:GRF
BME:GRFBiotechs

Does Grifols (BME:GRF) Phase 3 Bet Signal a Deeper Pivot in Its Immunology Strategy?

Grifols recently reported that the first patients have been dosed in two Phase 3 trials to expand U.S. labels for its flagship immunoglobulin therapies, GAMUNEX-C and XEMBIFY, targeting secondary immunodeficiency in certain blood cancers and chronic inflammatory demyelinating polyradiculoneuropathy. This push to broaden indications for existing plasma-derived products highlights how Grifols is trying to deepen its presence in complex, chronic immune-related conditions where immunoglobulin...
BME:ART
BME:ARTElectrical

European Export Stocks Getting A Tariff Edge In The US

The new US tariff regime under Section 301 is quietly reshaping the playing field for global exporters, and European stocks are right in the middle of it. With lower duties for key countries like France, the UK, Germany, Spain, Belgium, and Italy, and higher rates for rivals such as Brazil, some European exporters now sit in a more favorable position in US trade. This article looks at how that shift connects to large European companies on our European Exporters screener and reveals 3 stocks...
BME:CIE
BME:CIEAuto Components

Is CIE Automotive (BME:CIE) Undervalued After Strong Half Year Earnings?

CIE Automotive (BME:CIE) has drawn attention after reporting half year 2026 earnings, with sales, revenue, net income and earnings per share all higher than the figures reported a year earlier. See our latest analysis for CIE Automotive. Despite the stronger half year figures, CIE Automotive’s recent share price performance has been weak, with the stock at €25.8 and a year to date share price decline of 14.99%. However, the 5 year total shareholder return of 17.34% points to a more resilient...
BME:REP
BME:REPOil and Gas

Repsol (BME:REP) Stock Looks Cheap On Cash Flow Yet Pricey On Earnings

Repsol’s share price has delivered very strong gains over the past five years, yet there is a clear split in what current valuation tools are signalling, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to sizeable upside while market based multiples suggest the stock is closer to expensive territory. The stock has returned 256.9% over five years, which raises the bar for any further upside to be supported by fundamentals. Recent profit strength and expansion in areas...
BME:IDR
BME:IDRIT

Indra Sistemas (BME:IDR) Stock Tested As Q2 Margin Softness Challenges Bullish Thesis

Indra Sistemas (BME:IDR) has put solid headline figures on the table for Q2 2026, with revenue of about €1.9b, basic EPS of €0.81 and net income of €143.1m, giving investors plenty to weigh as earnings season rolls on. The company has seen revenue move from €1.29b in Q2 2025 to €1.9b in Q2 2026, while quarterly basic EPS has shifted from €0.88 to €0.81 over the same period, framing a mixed picture on the top and bottom lines. With trailing net profit margin sitting below last year’s level,...
BME:ROVI
BME:ROVIPharmaceuticals

Laboratorios Rovi (BME:ROVI) Stock Questioned As One Off Gain Lifts Reported Margins

Laboratorios Farmaceuticos Rovi (BME:ROVI) has released its Q2 2026 results with revenue of €191.7 million and net income of €75.0 million, set against trailing 12 month revenue of €773.1 million, net income of €185.2 million, and Basic EPS of €3.61 that reflects a 40% year over year earnings increase. Over recent quarters the company has seen revenue move from €159.7 million in Q2 2025 to €210.5 million in Q3 2025, €218.4 million in Q4 2025, €152.5 million in Q1 2026 and now €191.7 million...
BME:SAN
BME:SANBanks

Banco Santander (BME:SAN) Stock Highlights 26.6% Net Margin In Q2 2026 Earnings Narrative

Banco Santander (BME:SAN) has posted its Q2 2026 numbers with revenue of about €12.1 billion and net income from continuing operations of €3.7 billion, setting the tone for a results season where profitability stays front and center. The bank has seen quarterly revenue move from €11.6 billion in Q1 2025 to €12.5 billion in Q4 2025 and €12.1 billion in Q1 2026, while basic EPS shifted from €0.19 in Q1 2025 to €0.20 in Q4 2025 and €0.23 in Q1 2026, giving investors a clear run-up of the top and...
BME:REP
BME:REPOil and Gas

Is Repsol (BME:REP) Fully Valued After Its Nexa 95 Renewable Fuel Pilot?

Repsol (BME:REP) is back in focus after BMW Group and Toyota Motor Europe began a six month pilot in Spain using its Nexa 95 renewable gasoline, testing how fully renewable fuel fits into real world transport. See our latest analysis for Repsol. The Nexa 95 pilot comes at a time when Repsol’s share price has been strong, with a 30 day share price return of 17.8% and year to date share price return of 55.27%, alongside a 1 year total shareholder return of 101.92% that points to solid momentum...
BME:NTGY
BME:NTGYGas Utilities

Naturgy Energy Group (BME:NTGY) Stock Tests Bull Case As Net Margin Reaches 10.7%

Naturgy Energy Group (BME:NTGY) has reported Q2 2026 revenue of about €5.0 billion and net income, excluding extraordinary items, of €685 million, with the shares trading around €29.48 ahead of the market’s full verdict on these numbers. The company has seen quarterly revenue move between about €4.6 billion and €5.5 billion over the past six reported periods. Trailing twelve month net income, excluding extra items, stands at €2.1 billion, alongside trailing EPS of €2.21 as of Q1 2026, which...
BME:TLGO
BME:TLGOMachinery

Talgo (BME:TLGO) Stock Faces Narrowing Losses That Test Bullish Turnaround Narratives

Talgo (BME:TLGO) has just posted its H1 2026 scorecard, with revenue of €349.3 million and a loss of €34.2 million, translating to EPS of €0.27, while the trailing 12 month view shows revenue of €726.3 million and a loss of €59.9 million, or EPS of €0.46. The company has seen revenue move from €324.8 million and EPS of €0.99 in H2 2024 to €271.8 million and EPS of €0.52 in H1 2025, before reaching the latest H2 2025 and trailing 12 month levels. This gives investors a clearer sense of how the...
BME:CABK
BME:CABKBanks

3 European Dividend Stocks To Consider

The European market has experienced a mixed performance recently, with the pan-European STOXX Europe 600 Index remaining relatively stable amid global tech stock volatility and geopolitical tensions. As investors navigate these uncertain times, dividend stocks can offer a more stable income stream, making them an attractive option for those seeking to balance growth with consistent returns in their portfolios.
BME:ACS
BME:ACSConstruction

Is ACS Actividades De Construcción Y Servicios (BME:ACS) Fairly Valued As Coravel Launches?

Why the Coravel launch matters for ACS Actividades de Construcción y Servicios stock ACS Actividades de Construcción y Servicios (BME:ACS) is in focus after its Coravel data center joint venture with Global Infrastructure Partners secured a first major hyperscaler contract and formally launched its global platform. The agreement covers roughly 140 megawatts of IT load at Coravel's Dallas Fort Worth campus, with options for about 100 megawatts of additional capacity. Turner will build the...
BME:AEDAS
BME:AEDASReal Estate

Gibraltar Treaty Could Put Merlin Properties Stock Back On Investor Radars

Gibraltar’s new post Brexit treaty with the EU is reshaping the risk and opportunity map for real estate and infrastructure investors in the UK and Spain. Frictionless movement across the border, fresh land reclamation plans, tighter environmental rules, and ongoing political friction with Spain are all pulling in different directions. For stocks with meaningful exposure to housing, hotels, marinas and infrastructure in the region, this mix of potential growth and regulatory pressure matters...